Autoinjectors Market to Reach $5.73 Bn, Globally, by 2027 at 18.1% CAGR: Allied Market Research

News provided by

Sep 28, 2020, 09:00 ET

PORTLAND, Ore., Sept. 28, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, "Autoinjectors Market by Type (Disposable Autoinjectors and Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), and End user (Homecare Settings and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global autoinjectors industry was estimated at $1.50 billion in 2019, and is anticipated to hit $5.73 billion by 2027, registering a CAGR of 18.1% from 2020 to 2027.

Download Sample Report with Detailed COVID-19 Impact Analysis at: https://www.alliedmarketresearch.com/request-for-customization/1461?reqfor=covid

Drivers, restraints, and opportunities-

Rise in prevalence of anaphylaxis, increase in preference among patients to choose self-administration of injections, and technological advancements in autoinjectors fuel the growth of the global autoinjectors market. On the other hand, availability of alternative treatment options such as general injections and oral tablets impedes the growth to some extent. However, patent expiry of biologics to fuel biosimilar demands is expected to create lucrative opportunities for the key players in the industry.

COVID-19 scenario-

The outbreak of the pandemic has led to an increased demand for autoinjectors that can be used and monitored in the home environment.
At the same time, although COVID-19 has brought effects on many aspects such as travel bans and quarantines, the restrictive measures have not been imposed on the healthcare industry, thereby leaving the global autoinjectors market unaffected.

The disposable autoinjectors segment to dominate by 2027-

Based on type, the disposable autoinjectors segment accounted for more than two-thirds of the global autoinjectors market share in 2019 and is expected to rule the roost by the end of 2027. The same segment is also anticipated to register the fastest CAGR of 18.4% throughout the forecast period. This is because the key market players are highly focused on the development of autoinjector devices.

The home care settings segment to maintain the dominant share-

Based on end user, the home care settings segment contributed to more than three-fifths of the global autoinjectors market revenue in 2019 and is anticipated to lead the trail till 2027. Simultaneously, the same segment would also manifest the fastest CAGR of 18.3% during the study period. This is due to increased patient preference for autoinjectors and rise in prevalence of anaphylaxis.

North America garnered the major share in 2019-

Based on geography, North America generated the highest share in 2019, garnering more than two-fifths of the global autoinjectors market. This is attributed to higher awareness among people, increased adoption of autoinjectors, higher number of the target population, supportive reimbursement policies, and availability of advanced devices in the region. Asia-Pacific, on the other hand, would grow at the fastest CAGR of 18.6% from 2020 to 2027.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1461

Key players in the industry-

Antares Pharma
Becton Dickinson and Company
Johnson and Johnson
Mylan N.V.
Teva Pharmaceutical Industries Ltd
Eli Lilly and Company
Amgen
Novartis AG
SHL Medical
Ypsomed AG

Access AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) at:

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Self-Injections Market - Global Opportunity Analysis and Industry Forecast, 2020–2027

Intramuscular Injector Market - Global Opportunity Analysis and Industry Forecast, 2020–2027

Pneumonia Vaccine Market - Global Opportunity Analysis and Industry Forecast, 2020–2027

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research